Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 1.00 |
| ▸ | XDH | P47989 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.54 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.54 |
| ▸ | PNP | P00491 | 1/20 | 0.51 |
| ▸ | POLA1 | P09884 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9581457 | 0.94 | GDA (0.89) | GDAXDHKDM4EGAAFGFR1 | |
| 2-Pyrrolidone SCHEMBL9219915 | 0.87 | GDA (0.75) | GDAXDHKDM4EGAAFGFR1 | |
| SCHEMBL19466100 | 0.87 | GDA (0.76) | GDAXDHPNPPOLA1 | |
| SCHEMBL29411658 | 0.86 | GDA (0.76) | GDAXDHPNPPOLA1 | |
| SCHEMBL28559767 | 0.86 | GDA (0.75) | GDAXDHPNPPOLA1 | |
| SCHEMBL31093422 | 0.85 | GDA (0.74) | GDAXDHPNPPOLA1 | |
| SCHEMBL6821775 | 0.85 | GDA (0.74) | GDAXDHPNPPOLA1 | |
| SCHEMBL30510976 | 0.85 | GDA (0.74) | GDAXDHPNPPOLA1 | |
| SCHEMBL735411 | 0.84 | GDA (0.72) | GDAXDHPNP | |
| SCHEMBL1965519 | 0.84 | GDA (0.71) | GDAXDHPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114047262-B | Method for separating and measuring easily-hydrolyzed large polar compound | 湖北省宏源药业科技股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-115367745-B | Tungsten-containing substance hybridization and nitrogen-doped porous carbon material and preparation method thereof | 北京化工大学 | 2023-11-24 | — | — | CN | claimed |
| CN-115367726-A | Oxygen-doped titanium nitride hybridized and nitrogen-doped porous carbon material and preparation method and application thereof | 北京化工大学 | 2022-11-22 | — | — | CN | claimed |
| CN-115367745-A | Tungsten-containing substance hybrid and nitrogen-doped porous carbon material and preparation method thereof | 北京化工大学 | 2022-11-22 | — | — | CN | claimed |
| CN-114047262-A | Method for separating and measuring easily hydrolyzed large-polarity compound | 湖北省宏源药业科技股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-113735857-A | Acyclovir potential impurity and preparation method thereof | 湖北省宏源药业科技股份有限公司 | 2021-12-03 | — | — | CN | claimed |
| WO-2021238912-A1 | TRANSITION METAL COMPOUND-HYBRIDIZED AND NITROGEN-DOPED POROUS CARBON MATERIAL AND PREPARATION METHOD THEREFOR | 北京化工大学 | 2021-12-02 | — | — | WO | claimed |
| CN-111892047-A | Vanadium nitride hybrid and nitrogen-doped porous carbon material and preparation method and application thereof | 北京化工大学 | 2020-11-06 | — | — | CN | claimed |
| CN-107074911-B | Peptide nucleic acid monomers and oligomers | 优基艾森斯股份公司 | 2020-11-03 | — | — | CN | claimed |
| CN-108467396-A | A kind of preparation method of Ganciclovir | 安徽海康药业有限责任公司 | 2018-08-31 | — | — | CN | claimed |
| EP-1453833-A2 | A PROCESS FOR THE PREPARATION OF GANCICLOVIR INTERMEDIATE N2-ACETYL-9-(1,3-DIACETOXY-2-PROPOXYMETHYL) GUANINE | RANBAXY LABORATORIES, LTD. (IN) | 2004-09-08 | — | — | EP | claimed |
| US-20030198656-A1 | N-acetylamino acids, related N-acetyl compounds and their topical use | YU RUEY J (US) | 2003-10-23 | — | — | US | claimed |
| WO-2003033498-A2 | A PROCESS FOR THE TREATMENT OF GANCICLOVIR INTERMEDIATE N2-ACETYL-9-(1, 3-DIACETOXY-2-PROPOXYMETHYL) GUANINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-24 | — | — | WO | claimed |
| US-5780607-A | PYRANOSYL NUCLEOSIDE MONOMER UNITS CONNECTED BY AMIDE LINKAGES | HOFFMANN-LA ROCHE INC. (US) | 1998-07-14 | — | — | US | claimed |
| WO-1997014709-A1 | ANTISENSE OLIGOMERS | F. HOFFMANN-LA ROCHE AG (CH) | 1997-04-24 | — | — | WO | claimed |
| WO-1997011944-A1 | IMPROVED PROCESS FOR PRODUCING 9-(2-HYDROXYETHOXY)-METHYLGUANINE (ACYCLOVIR) | BOEHRINGER INGELHEIM KG (DE) | 1997-04-03 | — | — | WO | claimed |
| CN-1128269-A | Oligoribonucleotides with amide backbone | HOFFMANN LA ROCHE (CH) | 1996-08-07 | — | — | CN | claimed |
| EP-0714907-A1 | Oligoribonucleotides with amide backbone | F. HOFFMANN-LA ROCHE AG (CH) | 1996-06-05 | — | — | EP | claimed |
| WO-1992011276-A1 | NOVEL SYNTHESIS OF 2'-'UP' FLUORINATED 2''-DEOXY-ARABINOFURANOSYLPURINES | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1992-07-09 | — | — | WO | claimed |
| EP-0049072-A1 | Guanine compounds and their use for the preparation of anti-viral agents | SYNTEX (U.S.A.) INC. (US) | 1982-04-07 | — | — | EP | claimed |